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Dysfunction of the inwardly-rectifying potassium channels Kir4.1 (KCNJ10) represents a pathogenic 
mechanism contributing to Autism-Epilepsy comorbidity. To define the role of Kir4.1 variants in the 
disorder, we sequenced KCNJ10 in a sample of affected individuals, and performed genotype-phenotype 
correlations. The effects of mutations on channel activity, protein trafficking, and astrocyte function 
were investigated in Xenopus laevis oocytes, and in human astrocytoma cell lines. An in vivo model 
of the disorder was also explored through generation of kcnj10a morphant zebrafish overexpressing 
the mutated human KCNJ10. We detected germline heterozygous KCNJ10 variants in 19/175 affected 
children. Epileptic spasms with dysregulated sensory processing represented the main disease 
phenotype. When investigated on astrocyte-like cells, the p.R18Q mutation exerted a gain-of-function 
effect by enhancing Kir4.1 membrane expression and current density. Similarly, the p.R348H variant 
led to gain of channel function through hindrance of pH-dependent current inhibition. The frequent 
polymorphism p.R271C seemed, instead, to have no obvious functional effects. Our results confirm 
that variants in KCNJ10 deserve attention in autism-epilepsy, and provide insight into the molecular 
mechanisms of autism and seizures. Similar to neurons, astrocyte dysfunction may result in abnormal 
synaptic transmission and electrical discharge, and should be regarded as a possible pharmacological 
target in autism-epilepsy.
Dysfunction of the astrocyte K+ channel Kir4.1, encoded by the KCNJ10 gene (OMIM602208), is a common sub-
strate to a number of neuronal phenotypes in several syndromic or non-syndromic neurodevelopmental disor-
ders presenting with broad clinical manifestations and encompassing movement disorders, intellectual disability, 
autism spectrum disorders (ASD), and seizures1. Previous findings from clinical and functional investigations 
of KCNJ10 mutations (p.R18Q and p.V84M) in two unrelated families2 indicated that seizures, intellectual dis-
ability, and ASD (namely, the autism-epilepsy phenotype, AEP) were the main clinical presentation of patients 
with gain-of-function (GoF) mutations of the Kir4.1 channel. Heterologous expression of the variants in X. laevis 
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oocytes showed that an increase in single-channel conductance was clearly the cause of the GoF in p.V84M 
mutant channels. In the same cell model, we observed an increase in homomeric and heteromeric current ampli-
tudes with no changes in single-channel properties for mutant p.R18Q2, suggesting an enhanced surface expres-
sion as a possible, yet unexplored, GoF mechanism.
Following up on these preliminary findings, we have screened a larger sample of ASD individuals, either with 
or without comorbid epilepsy/EEG abnormalities, in order to establish the relative frequency of Kir4.1 variants in 
the clinical condition, and to draw further genotype-phenotype correlations. To explore in more depth the conse-
quences of new and already reported Kir4.1 variants, we have also assessed in vitro the effects of mutations on the 
complex functioning of astrocyte-neuron machinery, and their impact on clinical phenotypes in vivo.
Results
Clinical and genetic findings. The molecular screening of KCNJ10 in 175 affected children revealed three 
missense heterozygous variants (namely, p.R18Q, p.V84M, and p.R348H) in a total of 9/175 (5.1%) individuals. 
The three KCNJ10 variants were not found in any of our control DNA samples. Table 1 summarizes the main 
clinical findings of the patients harbouring the above mutations in KCNJ10. A more detailed clinical description 
is also reported in the Supplementary Data.
The c.53G > A (p.R18Q) variant in the cytoplasmic N-terminus domain was detected in 7/175 (4%) patients, 
five of whom were in the AEP subgroup. Seizures, when present, were well controlled under anti-epileptic drugs 
in all patients carrying the mutation p.R18Q. They displayed in addition a clear disorder of sensory processing 
regulation (hypersensitive, hyposensitive, sensory stimulation-seeking types). Among carrier relatives, two had 
clinical neuropsychiatric features. These included obsessive-compulsive symptoms and mood disorder in the 
mother of our original twin set2, and focal EEG abnormalities as well as subclinical manifestations of autism 
R18Q 7/175 (4%) R348H 1/175 (0.6%) V84M21/175 (0.6%)
Phenotype
 AEP (137, 78.3%) 5 1 1
 “Simplex” ASD (38, 21.7%) 2 0 0
Inheritance
 Maternal 4/7 (57.1%) — 1/1
 Paternal 2/7 (28.6%) 1/1 —
 Both — — —
 Unknown 1/7 (14.3%) — —
Gender
 Male 7/7 (100%) — 1/1
 Female — 1/1 —
ASD diagnosis
 Autism — — 1/1
 PDDNOS 7/7 (100%) 1/1 —
 Asperger’s syndrome — — —
Seizures
 Yes 3/7 (42.9%) 1/1 1/1
 No 4/7 (57.1%) — —
Type of seizures
 Focal — — 1/1
 Generalized 1/3 (33.3%) — —
 Spasms 2/3 (66.7%) 1/1 —
EEG abnormalities
 Yes 5/7 (71.4%) 1/1 1/1
 No 2/7 (28.6%) — —
EEG Site
 Anterior 3/5 (60%) — 1/1
 Posterior — — —
 Temporal — — —
 Multifocal/Diffuse 2/5 (40%) 1/1 —
Cognitive Development
 Normal-Borderline 1/7 (14.3%) — —
 Mild-Moderate Delay 5/7 (71.4%) — —
 Severe Delay 1/7 (14.3%) 1/1 1/1
Table 1.  Clinical features of individuals with KCNJ10 variants.
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involving social motivation, expressiveness, and flexibility/range of interest areas, assessed by the BPASS (Broader 
Phenotype Autism Symptom Scale)3, in another parent.
The novel c.1043G > A (p.R348H) (rs146396982), located at the cytoplasmic C-terminus domain of the Kir4.1 
protein, was detected in one girl with a history of epileptic spasms, beginning at four months of age, and mul-
tifocal EEG abnormalities. Spasms remitted without treatment two months later in connection with a febrile 
illness, and were followed by the development of a severe intellectual disability and ASD. The p.R348H variant 
was inherited from her father, who displayed severe anxiety disorder with panic attacks, and focal abnormalities 
on EEG recordings.
Lastly, we detected the c.811C > T (p.R271C) (rs1130183) in 10/175 (5.7%) individuals. This change is trusted 
as a neutral polymorphism because of its high frequency (MAF 0.04567) in polymorphic exome database (ExAC, 
exac.broadinstitute.org/) and in the 1000G dataset (www.1000genomes.org), and a benign prediction in silico 
using PolyPhen-2 (genetics.bwh.harvard.edu/pph2/), SIFT (SIFT, http://sift.jcvi.org/), and PANTHER (www.
pantherdb.org/tools/csnpScoreForm.jsp). Moreover, in our in house controls the p.R271C had a MAF of 0.0521.
KCNJ10 variants vs wild-type. To explore correlations between variants (namely, p.R18Q, p.V84M, and 
p.R348H) in KCNJ10 and phenotypic features, we compared wild-type (WT) individuals [166/175 (94.9%)] 
with those harbouring rare variants in KCNJ10 [9/175 (5.1%)] (Table 2). The two groups were comparable with 
respect to age, gender, ASD diagnosis, language and cognitive development, frustration intolerance, self/hetero 
injurious behaviours, sleep disorders, presence of macrocephaly, and family history for epilepsy and/or ASD 
(Supplementary Table S1). In addition, they did not differ for the rate of seizure history, nor in the occurrence, 
type and site of EEG abnormalities. We found that KCNJ10 variants were significantly associated with epileptic 
spasms (χ 2 = 11.131, df = 2, p = 0.004), with a particularly good prognosis of the epilepsy outcome. Finally, indi-
viduals with KCNJ10 variants showed a lower frequency of stereotyped behaviours (χ 2 = 4.217, df = 1, p = 0.040), 
and a higher occurrence of regulation disorders of sensory processing (χ 2 = 4.346, df = 1, p = 0.037) (see Table 2 
for details). Similar results were also seen when children harbouring the neutral p.R271C were removed from the 
WT group (see Supplementary Tables S2 and S3).
Functional findings. The p.R18Q mutation enhances membrane expression of Kir4.1 channels in astrocyte-like 
cells. We have previously shown that the R18Q mRNA injection into X. laevis oocytes resulted in larger Kir4.1 
currents than the WT, although the effects of this mutation were not assessed at the biochemical level and in a 
more physiological setting2. In newly generated U251MG astrocytoma cell lines stably expressing WT or R18Q 
WT (n = 166)
KCNJ10 Variants 




 Yes 58 (34.9%) 5 (55.6%) 1.575 0.095 0.210
 No 108 (65.1%) 4 (44.4%)
Type of Seizures
 Focal 37 (63.8%) 1 (20%) 11.131 0.420 0.004*
 Generalized 16 (27.6%) 1 (20%)
 Spasms 5 (8.6%) 3 (60%)
EEG abnormalities
 Yes 122 (77.7%) 7 (77.8%) 0.000 0.000 0.996
 No 35 (22.3%) 2 (22.2%)
Site of EEG abnormalities
 Anterior 41 (33.6%) 3 (42.9%) 2.947 0.151 0.400
 Posterior 18 (14.8%) 0
 Temporal 18 (14.8%) 0
 Multifocal/Diffuse 45 (36.8%) 4 (57.1%)
Type of EEG abnormalities
 Paroxysms 59 (48.4%) 4 (57.1%) 1.279 0.100 0.528
 Focal slowing 19 (15.6%) 0
 Both 44 (36%) 3 (42.9%)
Stereotyped Behaviours
 Yes 144 (87.8%) 3 (37.5%) 4.217 0.157 0.040**
 No 20 (12.2%) 5 (62.5%)
Regulation Disorder of Sensory Processing
 Yes 109 (66.9%) 9 (100%) 4.346 0.159 0.037***
 No 54 (33.1%) 0
Table 2.  Gain-of-function KCNJ10 variants (R18Q, R348H, V84M) vs WT. WT = Wild type; χ 2 = the 
Pearson chi-squared test; Φ c = Cramer’s phi coefficient; *KCNJ10 variants were significantly associated with 
epileptic spasms; **KCNJ10 variants showed stereotyped behaviours less frequently than WT; ***KCNJ10 
variants showed a Regulation Disorder of Sensory Processing more frequently than WT.
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channels, patch-clamp recordings showed that the averaged current densities of cells expressing the mutant chan-
nels were markedly larger than WT at both more positive and negative potentials than the K+ equilibrium poten-
tial (EK) (Fig. 1a–c). However, as shown in the dot plot of Fig. 1c (inset), the current density of cells expressing 
the mutant channel displayed a variability much higher than that observed in WT cells. The cell resting potential 
was on average ~4 mV more negative for R18Q compared to WT (Fig. 1d). To test the responsiveness of U251 
cells expressing Kir4.1 channels to abrupt elevations of extracellular K+, as it may occur in tripartite synapses 
during intense neuronal activity, 300 ms puffs of K+ (20 mM) were delivered onto cells while recording whole-cell 
currents (Vh–80mV). These assessments showed that the K+-induced inward current density, recorded from 
R18Q expressing cells, was larger than the WT (Fig. 1e,f). Overall, these results indicated that the R18Q mutation 
increases Kir4.1 currents regardless of the expression system used to establish this effect (U251MG cells vs X. 
laevis oocytes) and enhances the influx of K+ upon increments of the concentration of this ion in the extracellular 
compartment. To investigate the hypothesis that a different distribution of WT and mutated channels in astro-
cytoma cells could account for the effects described above, we carried out immunofluorescence and western blot 
(WB) experiments. We found that untransfected U251 cells expressed low levels of endogenous Kir4.1 channels 
that were almost exclusively localized in the cytoplasm (Supplementary Fig. S1a), as previously observed in other 
glioma cell lines4. Immunostaining of U251 cells expressing recombinant Kir4.1 indicated that WT channels were 
mostly localized in the cytoplasm, both within perinuclear areas and along cell extensions and scarcely at plasma 
membrane (Fig. 2a, arrows, top panels). By contrast, the majority of cells (~70%) expressing R18Q mutant showed 
Figure 1. Whole-cell Kir4.1 currents recorded from cells expressing WT and R18Q channels. Sample 
current traces for (a) WT and (b) R18Q channels expressed in U251 astrocytoma cells, obtained in response 
to voltage steps from − 140 to + 20 mV in 10 mV steps, from a holding potential of − 30 mV. (c) Mean current 
density (pA/pF) as a function of voltage obtained from cells expressing the indicated channels. Inset: scatter 
plot of the single-cell current densities at − 120 mV. The open symbols represent the mean ± SEM. (d) The 
resting membrane potentials were evaluated in current clamp conditions from cells expressing WT (black bar) 
or R18Q (grey bar) channels (data are mean ± SEM; **p < 0.01). (e) Sample inward-current densities evoked by 
puffs of an external solution containing 20 mM KCl from astrocytoma cells expressing the indicated channels 
(holding potential of − 80 mV). (f) WT (black circles) and R18Q (grey circles) current densities elicited from 
each cell using the experimental protocol described in panel e which were subsequently averaged and depicted 
(mean ± SEM; *p < 0.05).
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channels abundantly distributed along cell membranes, particularly in cell processes, filopodia-like structures 
and cell-cell contacts, where Kir4.1 partially co-localizes with actin (Fig. 2a, arrowheads bottom panels). RT-PCR 
analysis indicated that WT and R18Q cells expressed comparable levels of recombinant gene mRNAs, suggesting 
no differences in the infection levels between the two cell populations (Supplementary Fig. S1b). Consistently, 
WB analyses of protein derived from cytosol and total membranes (intracellular and plasma membrane) 
using anti-Kir4.1 Ab (Fig. 2b) or anti-epitope-tag Ab (Anti-Xpress) for the detection of recombinant channels 
(Fig. 2c,d) showed that R18Q channels were expressed more abundantly than WT protein in the membrane frac-
tion. Biotinylation experiments and WB analyses were then performed to specifically evaluate WT and mutant 
Kir4.1 protein expression at plasma membrane (see methods). Higher levels of mutant Kir4.1 were found at the 
cell surface when compared with WT protein (Fig. 2e). Interestingly, α -syntrophin (α -synt), a protein belonging 
to the dystrophin-associated glycoprotein complex (DGC) which anchors Kir4.1 to glial cell membranes, was 
detected at much higher levels in cell eluates containing mutant Kir4.1 protein when compared to WT. No differ-
ences were seen in the amounts of β-dystroglycan (β-DG) and aquaporin-4 (AQP4), two additional components 
of DGC bound to α -synt in glial cell plasma membranes (Fig. 2e). Co-immunostaining with α -syntrophin and 
Figure 2. WT and mutated Kir4.1 expression and distribution in U251 astrocytoma cells. (a) Co-
immunofluorescence staining of Kir4.1 WT and R18Q expressing cells using Anti-Xpress epitope Ab to stain 
recombinant Kir4.1 (red) and phallacidin to stain actin filaments (green) shows that WT channels are mostly 
localized in the cytoplasm, and at plasma membrane in a low percentage of cells (top panels, arrows), while R18Q 
mutant channels are mainly distributed along cell membranes, filopodia-like structures and cell-cell contacts 
(bottom panels, arrowheads), and partially co-localizes with actin, in the majority of cells (70%). (b,c) Western 
Blot (WB) analysis of total membrane and cytosolic protein extracts of astrocytoma cells expressing WT and 
R18Q Kir4.1, probed with anti Kir4.1 Ab (b) and Anti-Xpress epitope tag Ab (c) revealed that R18Q is more 
abundantly expressed in the cytoplasm (CYT) and particularly in the total membrane protein fraction (MEM), 
than the WT protein. Anti-Xpress epitope tag Ab does not detect Kir4.1 protein in the cytoplasm. Arrowheads 
on the right of panel b highlight the monomeric and oligomeric forms of the Kir4.1 channel. Actin is used as 
loading control. Molecular weight markers are on the left (kDa). (d) Densitometric analysis of recombinant 
Kir4.1 bands derived from total membrane protein extracts from WT or R18Q Kir4.1 expressing cells, detected 
by anti-Xpress Ab and normalized to the corresponding actin value (mean ± SEM, expressed as arbitrary 
units; *P < 0.05 from three independent experiments). (e) WB of total cell proteins (SM) and enriched 
fraction of plasma membrane proteins after biotinylation experiments (Eluates) probed with anti–Kir4.1 Ab. 
Higher amount of R18Q Kir4.1 is expressed at the plasma membrane (arrow) when compared to Kir4.1 WT. 
Among Kir4.1 associated proteins α -syntrophin (α -synt) is found at plasma membrane of Kir4.1 R18Q mutant 
expressing cells (asterisk) but not in WT expressing cells. No differences are observed in β -dystroglycan (β -DG) 
and AQP4 association to astrocytoma plasma membrane. One representative experiment out of two performed 
with the same results has been shown.
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Kir4.1 Abs indicated that the proteins co-localized in cells expressing the R18Q mutant in a higher percentage 
with respect to cells expressing the WT channel (Supplementary Fig. S2).
The p.R18Q mutation does not affect protein stability, membrane compartmentalization and molecular interactions. 
The enhancement of membrane expression and current density, induced by p.R18Q in the presence of normal 
mRNA expression, raised the possibility that these effects could result from increased stabilization of the mutant 
protein at the plasma membrane and alterations in protein degradation kinetics, similar to that observed for 
Kir2.1 channels carrying a mutation linked to AEP5. To verify this possibility, cells expressing WT and R18Q 
channels were treated for 3 and 6 h with cycloheximide (CHX) to inhibit protein synthesis. Subsequent WB anal-
ysis revealed no statistical differences in the degradation kinetics of WT and R18Q proteins (Fig. 3a). Since Kir4.1 
channels require cholesterol for their function6,7, and their distribution in cholesterol-enriched membrane rafts 
can modulate Kir4.1 channel activity6, we tested whether p.R18Q mutation could influence channel compartmen-
talization at astrocyte plasma membrane, as observed for the Kir2.1 mutant associated to AEP5. Analysis of Kir4.1 
protein distribution in sucrose gradient-isolated cholesterol-rich or poor membrane fractions indicated that both 
WT and mutant channels were equally distributed in cholesterol-poor membrane fractions (Fig. 3b), excluding 
that p.R18Q could alter compartmentalization of Kir4.1 channels in lipid raft. We also tested whether p.R18Q 
mutation could influence Kir4.1 interactions with proteins known to bind directly Kir4.1 channel or associate 
indirectly to it via α -synt binding in glial cells, such as Kir2.1, Kir5.1, AQP4, TRPV4 and connexin-436,8–11. We 
found the co-presence of Kir2.1, AQP4, Kir5.1, TRPV4, but not connexin-43, with Kir4.1 in the protein eluates, 
without significant differences between cells expressing WT and mutant channels (Fig. 3c).
Functional characterization of p.R348H and p.R271C variants. Using two-electrode voltage-clamp (TEVC) and 
patch-clamp recordings from X. laevis oocytes injected with equal amounts of WT or mutated Kir 4.1 mRNAs, 
we observed that both p.R348H and p.R271C mutant channels yielded currents with macroscopic kinetics equal 
to WT. Furthermore, the current/voltage relationships for both mutant channels showed current amplitudes 
and inward-rectification similar to WT. Patch-clamp single-channel recording showed similar conductance for 
WT, R271C and R348H channels which were 24.1 ± 0.3 pS, 25.3 ± 0.6 pS and 25.7 ± 0.4 pS (n = 5; p > 0.05), 
respectively. To assess whether mutations interfere with physiological channel turnover, current amplitude was 
monitored during the 10 days following mRNA injection into oocytes. Also in this case, the trend did not differ 
between WT and mutants (Fig. 4a,b). We therefore tested the effects of intracellular acidification on the WT 
and mutant channels in oocytes (Fig. 4c–h) because it has been established that Kir4.1 channels are inhibited by 
intracellular acidification and WT current amplitudes decrease when pHi is lowered to 6.112–14. We found that 
whilst the p.R271C did not affect the pHi sensitivity of the channel (Fig. 4e,f,h), the p.R348H variant reduced 
significantly the acidification-induced current inhibition at plateau (Fig. 4d,g,h). To further investigate the pHi 
sensitivity of WT and R348H channels, several pHi values were tested. Figure 4i shows that the R348H mutation 
caused a right-shift of the pHi/inhibition relationship compared to WT. The WT and R348H current sensitivity 
to intracellular acidification was also assessed using U251 cells stably expressing these channel types. Currents 
were recorded at − 100 mV using the whole-cell patch-clamp configuration and pipettes were filled with an intra-
cellular solution having pH values of either 7.2 or 6.1. Both WT and R348H current amplitudes recorded at pH 
7.2 were highly stable over time, after the establishment of the whole-cell configuration (Fig. 5a–d). Remarkably, 
the R348H currents were inhibited significantly less than the WT when a pipette solution at pH 6.1 was used 
(Fig. 5a–e). These recordings showed that the mean current densities for WT and R348H channels were similar 
also in U251MG cells (Fig. 5f), confirming the results obtained by using X. laevis oocytes (Fig. 4b). Collectively 
and consistently, these data showed that the R348H mutant channel displays a reduced sensitivity to intracellular 
acidification.
To assess whether the p.R348H and p.R271C variants influence Kir4.1 channel trafficking, we tested their pos-
sible alterations in expression and intracellular distribution in U251 cells. WB analysis (Supplementary Fig. S3a) 
and co-immunostainings (Supplementary Fig. S3b) indicated no differences among WT and mutant channels. 
Similarly, no significant differences were observed in the interactions of WT and mutant Kir4.1 with some of 
the main molecular interactors found in astrocytes (Supplementary Fig. S4). Overall, our data suggest that the 
p.R271C variant is benign, whereas the R348H variant most likely leads to GoF of Kir4.1 channels by reducing 
the pHi-sensitivity of the channel.
Based on crystal structure data, we finally generated a 3D-homology model of a Kir4.1 channel (See 
Supplementary Methods). The position of the Arg-18 residue in the N-terminal region could not be determined 
due to lack of structural data. However, the model suggests that the N-terminal, where the R18Q mutation is 
located, likely interacts with the C-terminal (Supplementary Fig. S5a). The analysis of this modelling also indi-
cated that the R348H mutation is located in the C-terminal region of the cytoplasmic domain of Kir4.1 channel 
(Supplementary Fig. S5b). A 3D-homology model for the R271C channel was also generated, showing that this 
mutation affects an arginine residue located in the intracellular domain and pointing towards the bulk solvent 
(Supplementary Fig. S6a,b).
In vivo modelling of Kir4.1 mutations in zebrafish (D. rerio). Using an established methodology15, transient 
knockdown of kcnj10a through morpholino (MO)-based technology led to macroscopic abnormalities in organ 
development (Fig. 6a), as well as 2- to 3-fold increases of spontaneous tail flicks in 30 hpf morphants (Fig. 6b–e). 
This pathological phenotype is consistent with data in morphants observed by others and possibly relates to 
neuronal hyperexcitability underlying epilepsy15. To test in vivo the effects of human Kir4.1 variants detected in 
AEP children on the disease phenotype seen in zebrafish, we also co-injected embryos with MO and equimolar 
amounts of either WT or mutated human KCNJ10 mRNA. While the WT and the R271C mRNA could rescue 
the number of spontaneous tail flicks to basal levels, the human mRNA harbouring each of R18Q, V84M and 
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R348H could not complement the diseased phenotype (Fig. 6b–e). A similarly abnormal locomotor behaviour 
was observed in WT embryos overexpressing the R18Q mutation, either alone or co-injected with the WT human 
mRNA, suggesting a GoF effect of the mutant allele (Supplementary Fig. S7).
Figure 3. Degradation kinetics, membrane compartmentalization and molecular interactions of WT  
and R18Q Kir4.1. (a) Left panel: WB analysis of protein extracts obtained from cells expressing WT and R18Q 
Kir4.1 channels treated with the protein synthesis inhibitor cycloheximide (CHX) for 3 and 6 h to inhibit 
protein synthesis and evaluate protein degradation kinetic. Anti-Xpress epitope Ab was used to detect WT 
and mutant Kir4.1. Actin is used as loading control. Molecular weight markers are on the left (kDa). Right 
panel: densitometric analysis of WT or R18Q Kir4.1 protein bands after CHX treatment, normalized to the 
corresponding untreated controls, indicates no significant differences in the degradation kinetics between WT 
and R18Q Kir4.1 proteins. Data are expressed as mean ± SEM from three independent experiments. (b) WB 
analysis of cholesterol-rich (Triton insoluble fractions: 4–7) and cholesterol-poor membrane fractions (Triton 
soluble fractions: 10–13) obtained from WT or R18Q Kir4.1 expressing cells shows that WT and mutant Kir4.1 
channels are both distributed in cholesterol-poor membrane fractions. Caveolin-1 and flotillin identify the 
caveolar raft fractions in cells expressing Kir4.1 WT. Molecular weight markers are on the left (kDa). (c) WB 
analysis of Kir4.1 channel interactors selected by Histidine (His) affinity chromatography. Eluates derived from 
astrocytoma cells infected with the empty vector (U251) were used as controls for unspecific binding to NiNTA-
resin. The Input lane indicates the total protein extracts before His pull-down assay and 200 mM and 50 mM 
the proteins eluted from NiNTA-resin using imidazole (50, 200 mM, respectively). Kir2.1, aquaporin-4 (AQP4), 
Kir5.1, TRPV4, but not connexin-43 were found among the proteins co-eluted with Kir4.1. No difference 
was observed between WT and R18Q Kir4.1 interactors. One representative experiment out of four is shown. 
Molecular weight markers are indicated on the left (kDa).
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Discussion
The inwardly-rectifying K+ channels Kir4.1 are strongly expressed in the brain, mainly in the cortex, thalamus, 
hippocampus, and brainstem16,17, where they regulate the astrocyte resting membrane potential, differentiation 
and K+ homeostasis. The polarized transport of K+ from regions of high [K+]o, resulting from synaptic excitation, 
to those of low [K+]o is essential to maintain the ionic and osmotic environment in the extracellular space, and to 
facilitate glutamate reuptake18–22. Although primarily expressed in astrocytes23, Kir4.1 channels are key regulators 
of neuronal excitability24, especially during high activity25, and of astroglial-dependent synaptic functions, such as 
hippocampal short-term plasticity26. When these mechanisms are impaired, they may impact on cognitive devel-
opment27, as well as motor function and susceptibility to seizures28. Conditional knock-out mice lacking Kir4.1 
in astrocytes manifest abnormal brain development, ataxia, seizures, and early postnatal death, thus supporting 
the crucial role of the channel for normal brain function19. Loss-of-function (LoF) defects of Kir4.1 (KCNJ10) have 
been linked to the autosomal recessive SeSAME/EAST Syndrome (MIM 612780)29,30, a condition encompassing 
clinical features such as sensorineural deafness, renal salt-losing tubulopathy, early onset seizures, ataxia, and 
severe intellectual disability. When modelled in zebrafish, LoF of Kir4.1 channels recapitulate the human disease 
in terms of epilepsy and behaviour15. Severe motor impairment (ataxia and myokymia) and seizures, but not 
hearing loss or renal impairment, are also the clinical manifestations seen in Russell Terriers dogs harbouring LoF 
homozygous mutations in KCNJ1031. Seizures, intellectual disability, and ASD, the features that define AEP, rep-
resent however the main clinical presentation of patients with GoF mutations of KCNJ102, confirming that Kir4.1 
Figure 4. WT, R271C and R348H channels expression pattern and pH-gating in X.laevis oocytes. Mean 
current amplitudes during 10 days post mRNA injection: (a) WT vs R271C, and (b) WT vs R348H. Sample 
current traces recorded at pHi 7.4 and 6.1 from WT (c), R348H (d), and R271C (e) expressing oocytes. Time 
course of current inhibition (%) of R271C vs WT (f), and R348H vs WT (g) upon K+-acetate pHi acidification 
from 7.4 to 6.1. All traces were recorded at − 100 mV from a holding potential − 10 mV. (h) Bar graph of pHi 
6.1-induced current inhibition (%) of the indicated channels. (i) pHi/inhibition relationships for WT (square) 
vs R348H (circles) assessed by using X. laevis oocytes and the K+-acetate pHi acidification method12–14.
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dysfunction likely increases the susceptibility to abnormal behaviour typical of ASD, in addition to epilepsy and 
cognitive impairment32,33.
With this in mind, we have collected a broader sample of ASD patients, with or without epilepsy, in order to 
screen KCNJ10 and perform genotype-phenotype correlations. We detected mutations (p.R18Q, p.V84M, and 
p.R348H) in nine children (5.1%), confirming that Kir4.1 defects are not an exceptionally rare event in AEP. 
Clinical investigations in our group of patients showed that gene variants were significantly associated with infan-
tile spasms, with a relatively good outcome, lower frequency of stereotyped behaviours, and augmented dysreg-
ulation of sensory processing profiles, when compared to non-mutation carriers (Table 2). Thus, these clinical 
features seem to define a possible Kir4.1-related endophenotype among the multitude of polymorphic conditions 
that characterize epilepsies and ASD34,35. We also observed that the p.R18Q variant was the most frequent muta-
tion in AEP, and that it causes GoF defects by promoting the trafficking of Kir4.1 channels at plasma membranes 
and enhancing K+ fluxes across cell membrane, that largely substantiate the data we had reported earlier using 
X. laevis oocytes2.
The strong role of astroglial Kir4.1 channels for K+ buffering is largely due to their high open probability at 
rest, and their increased conductance upon build-up of extracellular K+ concentrations25,36 that usually occurs 
in the brain during high neuronal activity. Immunofluorescence staining showed that the p.R18Q mutation 
promotes Kir4.1 channel expression particularly at the end-feet, the structures where K+ siphoning occurs. In 
addition, our patch-clamp recordings indicated that astrocyte-like cells expressing the p.R18Q possess an even 
increased ability to uptake extracellular K+ions compared to WT, when exposed to higher extracellular K+ con-
centration. A precise distribution of the K+ channels, accumulating at appropriate density in discrete subdomains 
of glial cell membranes, is a requirement for proper astrocyte-mediated K+ buffering activity, an essential process 
for the maintenance of optimal K+ concentrations in the extracellular environment, and consequently for correct 
synaptic functionality37,38. An altered homeostasis at the tripartite synapse, induced by GoF defects of Kir4.1 
channels in astrocytes, may represent therefore a possible mechanistic hypothesis linking our identified allelic 
variations with the increased susceptibility to seizures, as well as the behavioural and cognitive impairment.
Recent studies demonstrated that an AEP-related GoF mutation in Kir2.1 channels increased their stabiliza-
tion at the astrocytoma plasma membrane by hampering channel compartmentalization in membrane lipid rafts 
and the consequent caveolar-mediated endocytosis and proteasome degradation5. Differently from those findings, 
Kir4.1 mutations do not seem to influence channel degradation kinetics and lipid-raft distribution. Conversely, 
R18Q mutants seem to influence channel anchoring at plasma membrane. Biotinylation assays in astrocytoma 
plasma membrane revealed an increased expression in this compartment of the α -synt protein in cells expressing 
the mutant but not the WT channels. Accordingly, co-immunostainings indicated that co-localization of α -synt 
and Kir4.1 was higher in cells expressing the R18Q mutant than in cells expressing the WT Kir4.1. By binding 
directly to Kir4.1 intracellular COOH terminal, α -synt anchors channels to astrocyte plasma membrane keeping 
Figure 5. pH-gating of R348H channels expressed in astrocyte-like cells. Sample current traces for WT 
(a) and R348H (b) channel expressed in U251 cells, and recorded in the whole-cell configuration by applying 
voltage ramps from − 140 to + 30 mV (holding potential of − 80 mV), immediately after the establishment 
of the whole-cell configuration (pHi7.2), after 10 min (pHi6.1), and following external BaCl2 application 
(pHi6.1 + 100 μ M Ba2+). Both cells were recorded using an intracellular pipette solution having a pH of 6.1. 
(c,d) Representative time courses of WT (c) and R348H (d) currents recorded at − 100 mV (normalized to the 
current recorded immediately after the establishment of the whole-cell configuration), using a pipette solution 
with pH of either 7.2 (black circles) or 6.1 (grey circles). (e) Plot of the mean fractional WT and R348H current 
inhibition by an intracellular pH of either 7.2 or 6.1. The fractional current reduction was estimated at − 100 mV 
and calculated as 1− (I10 min/I0 min), in experiments similar to those shown in panels a–d. (f) Plot of the mean 
WT and R348H current density at − 100 mV of applied potential.
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them in close contact to DGC associated proteins, including AQP437. The localization of the R18 residue in the 
intracellular NH2 terminal of the Kir4.1 protein leads us to speculate that the mutation might influence the bind-
ing of α -synt at the COOH terminal by affecting the complex tridimensional molecular assembly characterizing 
the channel in vivo. Indeed, functional Kir4.1 channels are assembled into homo-tetramers where the NH2 ter-
minals lie between adjacent COOH residues and contribute to the formation of the interface between subunits 
(Supplementary Fig. S5)2,22. Moreover, the effects of p.R18Q mutation on the molecular interactions between 
Kir4.1 and α -synt seem to be specific, since no differences have been observed in the interactions with other 
proteins that, directly or indirectly via DGC, associate with Kir4.1 (i.e., Kir2.1, AQP4, Kir5.1, TRPV4) (Fig. 3). It 
is our opinion that the reinforced interaction of the Kir4.1 molecules to α -synt, induced by the mutation, could 
therefore mechanistically explain the increased amount of channels observed at astrocyte plasma membrane, and 
the consequent GoF of the R18Q channel.
The much rarer p.R348H, observed in a single child with AEP, was more difficult to reconcile with a GoF 
mechanism, biochemically, though it affected embryo locomotion and tail flicks behaving as the other two 
severe Kir4.1 variants (p.R18Q and p.V84M) when co-injected in zebrafish morphants (see Fig. 6d). TEVC and 
Figure 6. In vivo modelling of Kir4.1 mutations in zebrafish. (a) Transient kcnj10a knockdown zebrafish 
show macroscopic abnormalities in organ development compared to wild-type (WT). In morphant embryos, 
the pronephric duct is visible because it is dilated (black arrow); the swim bladder is not visible (white arrow). 
(b–e) Number of spontaneous tail flicks (registration time 30sec) seen in WT and mutant 30 hpf embryos. 
Values are expressed as percent of flicks counted in uninjected embryos. Embryos injected with MO (b–e), and 
with equimolar amount of MO and either R18Q (b), V84M (c), and R348H (d) mRNA show an increased rate 
of spontaneous contractions, compared to uninjected embryos (b–e), and to either MO+ WT (b–e) and MO+ 
R271C (e) mRNA injected embryos. **p < 0.01; ***p < 0.001.
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patch-clamp investigations showed that the p.R348H was less sensitive to intracellular acidification than WT. 
Glial cells undergo substantial intracellular pH changes, for instance during neuronal activity, in the presence of 
high levels of extracellular neurotransmitters39–41, or upon glutamate uptake42,43. Intracellular acidosis has also 
been associated with glutamate release from astrocytes44. Thus, the differential pH sensitivity of Kir4.1 channels 
carrying the R348H may result in significant functional consequences for the brain under critical conditions 
such as intense neuronal activity or build-up of neurotransmitters in the synaptic cleft. Noteworthy, an altered 
pH-gating of Kir channels has been also proposed as a new pathomechanism underlying antenatal Bartter syn-
drome type 2 (BS). Indeed, several LoF mutations in KCNJ1 (Kir1.1) have been associated with BS through a shift 
of pH sensitivity of Kir1.1 channels to more alkaline values45. Similarly, we might postulate a GoF effect due to 
altered pH-gating of Kir4.1 channels as a possible disease mechanism contributing to ASD, epilepsy, or to their 
concurrence. On the other hand, our investigations (both in cellular expression systems and in zebrafish) casted 
further doubts on a meaningful role for the p.R271C variant detected in 10 AEP children in keeping with previous 
results46. On the whole, our studies did substantiate the disease significance (though minor) of variants in Kir4.1 
in ASD and comorbid epilepsy and offered new possible molecular therapeutic targets in neurodevelopmental 
disorders.
A last consideration emerged from our preliminary observations in zebrafish. When compared to data gath-
ered by others in the SeSAME/EAST syndrome, we observed that GoF and LoF mutations in Kir4.1 appear to 
lead to a similar breakdown of complex homeostatic mechanisms that, through fine regulation of neuronal excit-
ability and synaptic activity, control the physiological development of crucial neurological functions. A possible 
explanation could be, indeed, that the mutant mRNA would result in a neomorphic protein with “toxic” GoF 
effect, i.e. due to the ectopic cellular expression of the mutant channels. It is hard to know, however, why the LoF 
phenotypes in the SeSAME/EAST syndrome are partially different compared to our children (i.e., a more severe 
ataxic disorder, or the presence of hearing and renal involvements not obvious in AEP). This could in part be 
explained by a milder functional impact of heterozygous gene variants (seen in AEP) compared to homozygous 
mutations seen in the SeSAME/EAST syndrome or that GoF and LoF mechanisms may affect the human neu-
rodevelopmental process in a different way and with different degrees of methylation-dependent transcriptional 
regulation, known to affect functional Kir4.1 channels during late foetal and early post-gestational life47,48, a time 
period where epigenetic processes critically fine-tune the neurodevelopmental program49. Regardless of these 
considerations, yet deserving further studies, our findings offer new insight on the complex machinery by which 
astrocytes might regulate neuronal excitability and synaptic function in ASD and seizures, and promote future 
investigations on the mechanisms by which the dysfunctional channels, or their molecular interactors, may be 
targeted by customized pharmacological treatments.
Materials and Methods
Patients and measures. A sample of 175 consecutive individuals with idiopathic ASD [24 F (13.7%) and 
151 M (86.3%), aged 2.0 to 20.8 years (7.5 mean ± 4.1 SD)], was divided in two groups: I) AEP (ASD with seizures 
and/or EEG abnormalities; 137/175, 78.3%) and II) “simplex” forms of ASD (with no history of seizures nor 
EEG abnormalities; 38/175, 21.7%). Individuals with non-idiopathic autism or symptomatic epilepsy had been 
excluded before enrolment. Phenotype characterization was carried out through clinical assessment, EEG study, 
and brain magnetic resonance imaging, as previously reported50–52. A family history for epilepsy or ASD was 
investigated up to the 4th degree of kinship. The presence of a parental BAP (broader autism phenotype)53 was 
assessed through the semi-structured interview BPASS3.
Statistical analyses, using the IBM© SPSS software version 20, were conducted in order to draw genotype-phenotype 
correlations. We used t-test for continuous variables, and the Chi-squared test to analyse categorical variables. A corre-
spondence analysis was used to decompose the significant Chi-squared and reduce variables dimensions. Significance 
level was set at p < 0.05. Statistically significant data are indicated by asterisks in the tables.
Genetic analyses. Total genomic DNA from peripheral blood was obtained from patients using standard 
purification protocols. Screening of variants in KCNJ10 was performed with Sanger sequencing as described2. 
Kir4.1 variants were also screened in a large cohort of in-house pooled control DNA samples (280 Italian indi-
viduals), and in 248 additional DNA samples (NA16129, NA1660, and NA16601) of different ethnicities from the 
Coriell Institute for Medical Research (Camden, NJ).
Functional assays in vitro. Generation and treatments of U251 astrocytoma cell lines expressing His-tagged 
Kir4.1 WT or carrying p.R18Q, p.R348H, or p.R271C variants. Astrocytoma U251MG cell lines were obtained 
from the American Type Culture Collection (Rockville, MD) and grown as previously described5. We generated 
and stably overexpressed His-tagged Kir4.1 either WT or carrying each of the three KCNJ10 variants investigated 
in this study (R18Q, R348H, R271C) in astrocytoma U251 cell lines using methodologies previously reported5. 
For cell treatments, astrocytoma cell lines were plated in 100-mm diameter dishes and treated for different time 
lengths (3h, 6h) with CHX (100 μ g/ml, Sigma).
Immunofluorescence and confocal microscopy analyses. Cells were grown subconfluent on polylysine-coated 
coverslips and fixed and stained using the following Abs: affinity purified anti-Xpress mAb (1:100, Life 
Technologies), anti-Kir4.1 pAb (1:50, Alomone Labs) and anti-syntrophin mAb (1: 50, Millipore) as primary 
Ab and TRITC-conjugated goat anti-mouse IgG Ab (1:100, Jackson Immunoresearch Laboratories), biotinylated 
goat anti-rabbit IgG H + L Ab (4.3 μ g/ml; Jackson Immunoresearch Laboratories, West Grove, PA) or Alexa Fluor 
488 goat antimouse IgG Ab (1:300, Invitrogen, Milan, Italy) as secondary Ab5. Actin filaments were stained using 
N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) (NBD)-phallacidin (1:30, Life Technologies). Coverslips were washed, 
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sealed in in ProLong Gold antifade reagent with 4,6-diamidino-2-phenylindole (Invitrogen) and analysed with a 
laser scanning confocal microscope (LSM 5 Pascal, Carl Zeiss, Jena, Germany).
Purification of histidine-tagged proteins by affinity chromatography. Lysates obtained from two T175 cm2 flasks 
of confluent astrocytoma cell lines stably expressing His-tagged WT or mutated Kir4.1 and mock infected con-
trol (U251) cells were used to perform the enrichment and purification of His-tagged proteins following already 
described procedures8. Fractions containing eluted protein were analysed by WB, as described below.
Detergent-resistant microdomain (DRM/lipid rafts) preparation by sucrose gradients. DRMs from cultured astro-
cytoma cell lines expressing His-tagged WT and mutated Kir4.1 were prepared essentially as described previ-
ously54. DRM fractions were visible as a light-scattering band migrating at approximately 20% sucrose (fractions 
4, 5, 6). Samples were precipitated overnight with acetone (1:4 v/v) and proteins analysed by SDS–PAGE and WB, 
as described below.
Protein extract preparation and Western blotting. Cytosolic, membrane fractions and total protein extracts 
from cultured astrocytoma cell lines were obtained as previously described8,54. Equal amounts of proteins (30 μ g) 
were resolved on SDS-PAGE using gradient (4–12%) precasted gels (Invitrogen), and transferred onto a nitro-
cellulose membrane. Nitrocellulose membranes were blotted overnight at 4 °C using the following primary Abs 
diluted in PBS/3% BSA: anti-Kir4.1 pAb (1:800, Alomone Labs), anti-Xpress mAb (1:2500, Life Technologies), 
anti-β -DG mAb (1:25, Novocastra Lab), anti-caveolin-1 pAb (1:1000, Santa Cruz Biotecnology), anti-Kir5.1 
pAb (1:500, Abcam), anti-flotillin mAb (1:1000, BD Transduction Laboratories), anti-syntrophin mAb (1:200, 
MA-1-745, Affinity BioReagents, CO), anti-TRPV4 pAb (1:200, Alomone Labs), anti-connexin-43 mAb (1:250, 
BD Transduction Laboratories), anti-Kir2.1 pAb (1:250, Alomone Labs), anti-aquaporin-4 mAb (1:200, Santa 
Cruz Biotecnology), anti-actin mAb (1:2000, Santa Cruz Biotecnology). As secondary Abs we used peroxidase 
conjugated anti-mouse or anti-rabbit Abs (1:10000; Thermo Scientific, MO), for 1 hour at room temperature 
(RT). Immunoreactive bands were visualized using an enhanced chemiluminescence reagent (Thermo Scientific), 
according to the manufacturer’s instructions and exposed on X-ray films.
Cell surface protein biotinylation. Cell surface protein biotinylation assay was performed using a commercially 
available biotinylation kit (Thermo Scientific), following previously described procedures55. Fractions containing 
eluted proteins were analysed by WB, as described above.
Expression of Kir4.1 channels in X. laevis oocytes. The human Kir4.1 constructs were generated as previously 
described2. Stages IV–V X. laevis oocytes were isolated, injected with 50 nl mRNAs and stored at 16 °C in fresh 
ND96 medium containing (in mmol/L): NaCl 96, KCl 2, MgCl2 1, CaCl2 1.8, Hepes 5, gentamicin 50 μ g/ml 
(Sigma, Italy). mRNA concentrations were quantified by electrophoresis and ethidium bromide staining and 
by spectrophotometric analysis. Equal amount of either WT or mutant mRNAs were then microinjected into 
oocytes2.
Electrophysiology. TEVC recordings were performed from oocytes at RT (22 °C) and 1–10 days after injection by 
using a GeneClamp 500 amplifier (Axon Instruments, Foster City, CA) interfaced to a PC with an ITC-16 inter-
face (Instrutech Corporation, Longmont, CO), as previously described56,57. Standard recording solution contained 
(in mmol/L): KCl 90, MgCl2 3, Hepes 10 (pH 7.4). Recordings were filtered at 2 kHz and acquired at 5 kHz with 
Pulse software and analysed with either PulseFit (HEKA, Germany) or IGOR (WaveMetrics, Lake Oswego, OR)58. 
Intracellular acidification was achieved using a potassium acetate buffering system12,59. Only one pH/inhibition 
value per cell was determined in TEVC experiments as previously described13,14. To assess the effects of intracel-
lular acidification we used a well-established potassium acetate buffering system able to modify the intracellular 
pH of oocytes59.
Patch-clamp recordings were performed in X. laevis oocytes using the cell-attached and inside-out configura-
tion at 22 °C and an Axopatch 200B amplifier (Axon Instruments) as described60. Briefly, oocytes were bathed in 
a cytoplasmic solution containing (in mmol/L) KCl 120, CaCl2 1, EGTA 11, Hepes 10, dithiothreitol 0.1 (pH 7.2). 
Recording electrodes were filled with a solution containing (in mmol/L) KCl 120, Hepes 10, CaCl2 0.2 (pH 7.2) 
and had resistance of 3–8 MΩ. Channel activity was analysed with a TAC-TACFit program (Bruxton Co., Seattle, 
WA) and channel openings were visually inspected before being accepted (event-by-event mode). Recordings in 
U251MG cells were performed using an Axopatch 200B Amplifier (Axon Instruments), at RT as described5. The 
extracellular recording solution contained (in mmol/L) NaCl 140, KCl 5, CaCl2 2, MgCl2 2, MOPS 5, glucose 20, 
(pH 7.4 with NaOH). In experiments where cells were puffed with high extracellular K+, KCl was increased to 
20 mM and NaCl was decreased to 125 mM. The micropipette solution contained (in mmol/L) KCl 155, EGTA-K 
1, MOPS 5, MgCl2 1 (pH 7.2 or 6.1, when indicated, with KOH). To show Kir4.1 specificity, 100 μ mol/L BaCl2 was 
added to the bath solution to block the inward rectifying current.
All the data are presented as mean ± SEM. Two-tailed Student’s t-test was used to compare means and statistic 
level was set with significance at p < 0.05.
Generation of kcnj10a morphant zebrafish and co-injection with human Kir4.1 variants. 
Zebrafish kcnj10a, the orthologue of human KCNJ10, has already been cloned, and experimental procedures 
to study gene expression (load and site), to generate morphant embryos, and to investigate the significance of 
human mutations have already been described elsewhere15. To transiently knockdown the Kir4.1 function in 
zebrafish, we adopted an already established protocol using MO (Gene Tools, USA) targeting the splice site 
(5-AATTGTGAGAGCTATACCTTGGCGA-3) of kcnj10a, diluted into RNAse free water, and injected into 
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one- to two-cell stage embryos15. The embryos were raised at 28.5 °C. For rescue experiments, human WT and 
R18Q, V84M, R348H, and R271C cDNAs were cloned in a pCS2 + vector. The capped mRNA was obtained using 
mMESSAGE mMACHINE SP6 transcription Kit (Life technologies, Carlsbad, CA), and 50 pg of human WT or 
mutant KCNJ10 cRNA were co-injected with 0.5 ng of kcnj10a MO.
Spontaneous contraction and rescue analyses in zebrafish larvae. To test the effects of human Kir4.1 mutations 
on embryonic phenotype, we injected one-cell stage eggs with both MO and equimolar amounts of either WT, or 
R271C polymorphism, or mutated human mRNA, and compared spontaneous contractions at 30 hpf in injected, 
uninjected and morphant embryos. A dominant-negative effect of the mutant allele was also investigated by 
injecting one-cell stage eggs with either the R18Q or WT human mRNA alone, or with equimolar amounts of 
WT + R18Q human mRNA, and by comparing the resulting phenotypes61. Locomotor activity (15 embryos for 
each group in triplicate) was recorded for 180 sec, and the number of complete tail contractions measured in 
30 sec time frames. Video recordings were made with Leica M80 microscope with Nikon Digital Sight DS-Fi1 
camera and the NIS Elements software package (Nikon, Nikon Corp., Europe), and a digital video camera using 
the CamStudio software. Tail flicks counting data were placed in Prism (GraphPad) to generate graphs and to 
perform statistical analyses (unpaired two-tailed Mann-Whitney U-test of all pairwise combinations).
Ethics Statement. All study protocols were approved by the Research Ethics Committee of the IRCCS Stella 
Maris Foundation, Pisa (Italy). All patients or their parents signed an informed consent prior to the assessment, 
and agreed for their medical data to be used anonymously in the research. All clinical procedures were carried out 
in accordance with the approved guidelines.
Procedures involving X. laevis and their care were in accordance with the regulations of the Italian Animal 
Welfare Act and in agreement with the NIH Guide for the Care and Use of Laboratory Animals. All experimental 
protocols were approved by the OPBA (Organismo Preposto al Benessere degli Animali) licensing body of the 
University of Perugia (Italy). The minimal number of animals was used.
Experiments in D. rerio were performed at the Italian National Research Council (NRC)-zebrafish core facil-
ity, in accordance with, and under the supervision of, the Institutional Animal Care and Use Committee (IACUC) 
of the University of Pisa and the NRC. All experimental protocols were approved by the animal ethics committee 
of the University of Pisa-NRC-Fondazione Monasterio. Animals were always managed and injected according 
to the principles of Good Animal Practice as defined by the Italian animal welfare regulations. Every effort was 
made to minimize animal suffering and to use the minimum number of animals necessary to collect reliable 
scientific data.
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